Cargando…
Rational design of innate defense regulator peptides as tumor vaccine adjuvants
The development of adjuvants has been an empirical process. Efforts to develop a new design and evaluation system for novel adjuvants are not only desirable but also necessary. Moreover, composite adjuvants that contain two or more types of adjuvants to synergistically enhance the immune response ar...
Autores principales: | Tian, Yaomei, Hu, Qiuyue, Zhang, Rui, Zhou, Bailing, Xie, Daoyuan, Wang, Yuanda, Zhang, Xueyan, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138013/ https://www.ncbi.nlm.nih.gov/pubmed/34016984 http://dx.doi.org/10.1038/s41541-021-00334-3 |
Ejemplares similares
-
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019) -
A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy
por: Zhang, Rui, et al.
Publicado: (2023) -
Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rui, et al.
Publicado: (2019) -
The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
por: Tian, Yaomei, et al.
Publicado: (2017) -
Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo
por: Zhao, Binyan, et al.
Publicado: (2021)